A detailed history of Options Solutions, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Options Solutions, LLC holds 132,994 shares of XERS stock, worth $1.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
132,994
Previous 85,111 56.26%
Holding current value
$1.3 Million
Previous $467,000 32.98%
% of portfolio
0.2%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$3.95 - $5.16 $189,137 - $247,076
47,883 Added 56.26%
132,994 $621,000
Q1 2025

May 15, 2025

BUY
$3.2 - $5.95 $272,355 - $506,410
85,111 New
85,111 $467,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $1.33B
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Options Solutions, LLC Portfolio

Follow Options Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Options Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Options Solutions, LLC with notifications on news.